NASDAQ : ARAY

Accuray Incorporated

$0.2749 USD

$0.01 (4.13%)

Volume
615.44K
Average Volume
3.46M
Market Capitalization
$32.7M
P/E Ratio
-0.74
Dividend Yield
0.00%
Price Target
$2.00
Year High
$2.10
Year Low
$0.24
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.42
Source Headline
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Commercial Officer and David Shin, the company's new Chief Legal Officer.

prnewswire.com - 2026-05-29 16:10:00

Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer

MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive radiation therapy platform.

prnewswire.com - 2026-05-15 16:05:00

Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript

Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-07 04:41:20

Accuray Reports Fiscal 2026 Third Quarter Financial Results

MADISON, Wis., May 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026.

prnewswire.com - 2026-05-06 16:05:00

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m.

prnewswire.com - 2026-04-22 16:05:00

Accuray (ARAY) to Release Quarterly Earnings on Wednesday

Accuray (NASDAQ: ARAY - Get Free Report) is anticipated to issue its Q3 2026 results after the market closes on Wednesday, April 29th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $111.90 million for the quarter. Parties are encouraged to explore the company's upcoming Q3 2026 earning overview page for

defenseworld.net - 2026-04-22 04:40:29

Get ARAY Insider Trade Alerts

ARAY Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$2.00

1 analysts

All Time

$5.00

3 analysts

ARAY Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-05-12 Jefferies Downgrade Buy Hold
2026-05-07 BTIG Downgrade Buy Neutral
2026-02-05 BTIG Maintain Buy Buy
2025-11-06 BTIG Maintain Buy Buy
2025-08-14 BTIG Maintain Buy Buy
2023-10-04 B. Riley Securities Maintain Buy Buy
2022-08-31 B. Riley Securities Maintain Buy Buy
2022-06-24 BTIG Maintain Buy Buy
2022-06-23 B. Riley Securities Maintain Buy Buy
2021-12-22 Loop Capital Maintain Buy Buy
2020-01-21 BTIG Upgrade Neutral Buy
2020-01-21 BTIG Research Upgrade Neutral Buy
2018-11-01 Citigroup Upgrade Sell Neutral
2018-08-17 Citigroup Maintain Sell Sell
2017-12-19 JP Morgan Downgrade Neutral Underweight
2017-12-13 JP Morgan Downgrade Neutral Underweight
2017-11-30 Lake Street Maintain Buy Buy
2017-08-23 Jefferies Maintain Buy Buy
2017-02-06 Aegis Capital Maintain Buy Buy
2016-12-14 JP Morgan Downgrade Overweight Neutral
2016-09-13 Cowen & Co. Maintain Outperform Outperform
2015-12-22 RBC Capital Maintain Sector Perform Perform
2015-11-12 Citigroup Maintain Sell Sell
2015-01-12 Northland Securities Maintain Outperform Outperform
2014-06-13 JP Morgan Upgrade Neutral Overweight
2014-03-11 BTIG Research Maintain Buy Buy
2014-01-31 JP Morgan Maintain Neutral Neutral
2013-09-20 JP Morgan Upgrade Underweight Neutral
2013-08-28 Jefferies Maintain Buy Buy
2013-01-04 Jefferies Maintain Buy Buy
2013-01-04 JP Morgan Downgrade Neutral Underweight
2012-10-26 Brean Capital Maintain Buy Buy
2012-10-09 Jefferies Maintain Buy Buy
2012-09-07 Jefferies Maintain Buy Buy
2012-02-09 JP Morgan Maintain Neutral Neutral